Ticker ANCN – Anchiano Therapeutics – sales, description, marketcap – Tickerday.com

ANCN

Anchiano Therapeutics

Index: NASDAQ; Sector: ; Industry: ;

Marketcap: ; Volume: 75.49K; AvgVol 3m: 97.27K; Beta: ;

Cost estimate:

P/E: ; EPS: ; EPS growth quarter/prev quarter: ;

EPS growth this year: 91.10%; EPS growth past 5 years: ;

EPS ttm: -2.67;

P/S: ; P/B: 01.07; P/Cashflow: ; P/FCF: ;

Sales: ; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 18.97%; Insider Transactions:0.00%;

Institutional Ownership: 27.81%; Institutional Transactions: ;

Data update: 07/10/2020.

Leave a comment

Your email address will not be published. Required fields are marked *